Cited by 39Gastroesophageal reflux and treatmentsDental Erosion and TreatmentHelicobacter pylori-related gastroenterology studies

Health-related quality of life of patients with acute erosive reflux esophagitis

Mathias, Susan D., Castell, Donald O., Elkin, Eric P., Matosian, Melissa L.·1996·Digestive Diseases and Sciences

Abstract

One thousand one hundred forty-five patients with acute erosive reflux esophagitis participating in an eight-week double-blind, multicenter study of lansoprazole 15 mg daily, lansoprazole 30 mg daily, omeprazole 20 mg daily, and placebo responded to a health-related quality of life (HRQoL) questionnaire at baseline and at two, four, and eight weeks. At baseline, there were no HRQoL differences among the four study groups. However, all three active treatment groups improved statistically significantly more than placebo on most HRQoL scales at each follow-up. There were no statistically significant differences among the three active treatment groups at week 2, although in most instances lansoprazole 30 mg showed slightly more improvement. After week 2, benefits in all the study groups leveled off and remained constant. Greater acid suppression appeared to result in greater improvement in terms of HRQoL.

Integrity signals

Registry

Crossref · 10.1007/bf02071390

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mathias, S. D., Castell, D. O., Elkin, E. P., & Matosian, M. L.
Affiliations
Graduate Hospital (US)
Venue
Digestive Diseases and Sciences
Published
1996-11
Volume
41
Issue
11
Pages
2123-2129
ISSN
  • 0163-2116 (ISSN-L)
  • 1573-2568
OpenAlex
W2027677946
Cited by
39
References
23
Citations by year
2016: 1
FWCI
2.84
Type
journal article
Language
en
Open access
closed
Locations
  • Digestive Diseases and Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Dentistry › Orthodontics › Dental Erosion and Treatment
  • Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
Keywords
health-related quality of life, erosive reflux esophagitis, lansoprazole, omeprazole, proton pump inhibitors, acid suppression, gastroesophageal reflux disease, placebo comparison
MeSH terms
Acute Disease, Analysis of Variance, Double-Blind Method, Enzyme Inhibitors, Esophagitis, Peptic, Female, Humans, Male, Middle Aged, Omeprazole, Quality of Life, Surveys and Questionnaires, Reproducibility of Results, 2-Pyridinylmethylsulfinylbenzimidazoles, Proton Pump Inhibitors, Lansoprazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review